171 related articles for article (PubMed ID: 16542460)
41. Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy.
Tumbarello M; Sali M; Trecarichi EM; Leone F; Rossi M; Fiori B; De Pascale G; D'Inzeo T; Sanguinetti M; Fadda G; Cauda R; Spanu T
Antimicrob Agents Chemother; 2008 Sep; 52(9):3244-52. PubMed ID: 18591273
[TBL] [Abstract][Full Text] [Related]
42. Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Bacteria Isolated from Patients Hospitalized with Pneumonia in U.S. Medical Centers, 2011 to 2015.
Sader HS; Castanheira M; Flamm RK
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28069649
[TBL] [Abstract][Full Text] [Related]
43. Epidemiology and Burden of Bloodstream Infections Caused by Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceae in a Pediatric Hospital in Senegal.
Ndir A; Diop A; Faye PM; Cissé MF; Ndoye B; Astagneau P
PLoS One; 2016; 11(2):e0143729. PubMed ID: 26867226
[TBL] [Abstract][Full Text] [Related]
44. Prevalence of Extended-Spectrum β-Lactamases in Multi-drug Resistant
Ul Hassan F; Qudus MS; Sehgal SA; Ahmed J; Khan M; Ul Haq K; Mumtaz S; Arshad M; Siraj S
Endocr Metab Immune Disord Drug Targets; 2019; 19(4):443-448. PubMed ID: 30484414
[TBL] [Abstract][Full Text] [Related]
45. Characterization of antibiotic resistance profiles in Pseudomonas aeruginosa isolates from burn patients.
Tchakal-Mesbahi A; Metref M; Singh VK; Almpani M; Rahme LG
Burns; 2021 Dec; 47(8):1833-1843. PubMed ID: 33795157
[TBL] [Abstract][Full Text] [Related]
46. Molecular epidemiology and multidrug resistance mechanisms of Pseudomonas aeruginosa isolates from Bulgarian hospitals.
Vatcheva-Dobrevska R; Mulet X; Ivanov I; Zamorano L; Dobreva E; Velinov T; Kantardjiev T; Oliver A
Microb Drug Resist; 2013 Oct; 19(5):355-61. PubMed ID: 23600605
[TBL] [Abstract][Full Text] [Related]
47. Detection of Pseudomonas aeruginosa isolates producing VEB-type extended-spectrum beta-lactamases in the United Kingdom.
Woodford N; Zhang J; Kaufmann ME; Yarde S; Tomas Mdel M; Faris C; Vardhan MS; Dawson S; Cotterill SL; Livermore DM
J Antimicrob Chemother; 2008 Dec; 62(6):1265-8. PubMed ID: 18819973
[TBL] [Abstract][Full Text] [Related]
48. Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007-2015).
De Angelis G; Fiori B; Menchinelli G; D'Inzeo T; Liotti FM; Morandotti GA; Sanguinetti M; Posteraro B; Spanu T
Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1627-1636. PubMed ID: 29948360
[TBL] [Abstract][Full Text] [Related]
49. Nosocomial bloodstream infections caused by Klebsiella pneumoniae: impact of extended-spectrum beta-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence.
Marra AR; Wey SB; Castelo A; Gales AC; Cal RG; Filho JR; Edmond MB; Pereira CA
BMC Infect Dis; 2006 Feb; 6():24. PubMed ID: 16478537
[TBL] [Abstract][Full Text] [Related]
50. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
[TBL] [Abstract][Full Text] [Related]
51. Detection of extended-spectrum beta-lactamase in Pseudomonas aeruginosa.
Aggarwal R; Chaudhary U; Bala K
Indian J Pathol Microbiol; 2008; 51(2):222-4. PubMed ID: 18603687
[TBL] [Abstract][Full Text] [Related]
52. Clinical and bacterial characteristics of Pseudomonas aeruginosa affecting the outcome of patients with bacteraemic pneumonia.
Recio R; Viedma E; González-Bodí S; Villa J; Orellana MÁ; Mancheño-Losa M; Lora-Tamayo J; Chaves F
Int J Antimicrob Agents; 2021 Dec; 58(6):106450. PubMed ID: 34644604
[TBL] [Abstract][Full Text] [Related]
53. Prevalence and impact of extended-spectrum β-lactamase production on clinical outcomes in cancer patients with Enterobacter species bacteremia.
Kim SJ; Park KH; Chung JW; Sung H; Choi SH; Choi SH
Korean J Intern Med; 2014 Sep; 29(5):637-46. PubMed ID: 25228840
[TBL] [Abstract][Full Text] [Related]
54. Antibiotic Susceptibility Patterns of Extended Spectrum beta-lactamase and non Extended Spectrum beta-lactamase Pseudomonas aeruginosa Clinical Isolates.
Akbariqomi M; Ghafourian S; Taherikalani M; Mohammadi S; Pakzad I; Sadeghifard N
Recent Pat Antiinfect Drug Discov; 2015; 10(2):128-33. PubMed ID: 26324233
[TBL] [Abstract][Full Text] [Related]
55. Comparison of the Treatment Outcome of Piperacillin-Tazobactam versus Carbapenems for Patients with Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli in Areas with Low Frequency of Coproduction of OXA-1: a Preliminary Analysis.
Hoashi K; Hayama B; Suzuki M; Sakurai A; Takehana K; Enokida T; Takeda K; Ohkushi D; Doi Y; Harada S
Microbiol Spectr; 2022 Aug; 10(4):e0220622. PubMed ID: 35916524
[TBL] [Abstract][Full Text] [Related]
56. Nosocomial infections with metallo-beta-lactamase-producing Pseudomonas aeruginosa: molecular epidemiology, risk factors, clinical features and outcomes.
Lucena A; Dalla Costa LM; Nogueira KS; Matos AP; Gales AC; Paganini MC; Castro ME; Raboni SM
J Hosp Infect; 2014 Aug; 87(4):234-40. PubMed ID: 25027563
[TBL] [Abstract][Full Text] [Related]
57. [Emergence of extended-spectrum beta-lactamases in Pseudomonas aeruginosa: about 24 cases at Rouen University Hospital].
David M; Lemeland JF; Boyer S
Pathol Biol (Paris); 2008; 56(7-8):429-34. PubMed ID: 18835668
[TBL] [Abstract][Full Text] [Related]
58. Antimicrobial Activity of Ceftolozane-Tazobactam, Ceftazidime-Avibactam, and Cefiderocol against Multidrug-Resistant Pseudomonas aeruginosa Recovered at a German University Hospital.
Weber C; Schultze T; Göttig S; Kessel J; Schröder A; Tietgen M; Besier S; Burbach T; Häussler S; Wichelhaus TA; Hack D; Kempf VAJ; Hogardt M
Microbiol Spectr; 2022 Oct; 10(5):e0169722. PubMed ID: 36190424
[TBL] [Abstract][Full Text] [Related]
59. Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa.
Gudiol C; Albasanz-Puig A; Laporte-Amargós J; Pallarès N; Mussetti A; Ruiz-Camps I; Puerta-Alcalde P; Abdala E; Oltolini C; Akova M; Montejo M; Mikulska M; Martín-Dávila P; Herrera F; Gasch O; Drgona L; Paz Morales H; Brunel AS; García E; Isler B; Kern WV; Morales I; Maestro-de la Calle G; Montero M; Kanj SS; Sipahi OR; Calik S; Márquez-Gómez I; Marin JI; Gomes MZR; Hemmatti P; Araos R; Peghin M; Del Pozo JL; Yáñez L; Tilley R; Manzur A; Novo A; Carratalà J;
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015035
[TBL] [Abstract][Full Text] [Related]
60. Clinical significance of infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae blood isolates with inducible AmpC β-lactamase.
Cheong HS; Ko KS; Kang CI; Chung DR; Peck KR; Song JH
Microb Drug Resist; 2012 Aug; 18(4):446-52. PubMed ID: 22409779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
